Target Name: LOC105379007
NCBI ID: G105379007
Review Report on LOC105379007 Target / Biomarker Content of Review Report on LOC105379007 Target / Biomarker
LOC105379007
Other Name(s): Uncharacterized LOC105379007, transcript variant X1 | LOC105379007 variant X1 | uncharacterized LOC105379007

LOC105379007: A Potential Drug Target and Biomarker

LOC105379007 is a gene that has not yet been fully characterized, but it is known to encode a protein with multiple functions, including interaction with various cellular signaling pathways. Several studies have identified LOC105379007 as a potential drug target and biomarker, which could be useful for the development of new therapeutic approaches for various diseases.

The protein encoded by LOC105379007 is highly conserved across various species, which suggests that it has a important role in fundamental cellular processes. It is known to play a role in the regulation of cell adhesion, which is a critical process that helps maintain the integrity of tissues and organs.

LOC105379007 has been shown to interact with several signaling pathways, including the NF-kappa pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and maintenance of tissues and organs.

Studies have also shown that LOC105379007 is involved in the regulation of the Wnt pathway, a critical pathway involved in the development and maintenance of neural tissues. The Wnt pathway is also involved in the regulation of cell adhesion and has been implicated in the development of several diseases, including cancer.

In addition to its role in cell signaling pathways, LOC105379007 has also been shown to play a role in the regulation of cellular homeostasis. This is important for maintaining the stability of cellular processes and is critical for the survival of cells and organisms.

The potential drug target status of LOC105379007 is supported by several studies, which have identified it as a potential target for small molecules and antibodies. Studies have shown that LOC105379007 can be targeted by small molecules, such as inhibitors of tyrosine kinase, which is a key enzyme involved in the NF-kappa pathway. In addition, LOC105379007 has been shown to be an attractive target for antibodies, which could be used to selectively target the protein and improve its sensitivity to therapeutic interventions.

The potential biomarker status of LOC105379007 is also supported by several studies, which have shown that it is involved in several important cellular processes, including cell adhesion, cell survival, and cellular homeostasis. This suggests that LOC105379007 could be used as a biomarker for several diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In conclusion, LOC105379007 is a gene that has not yet been fully characterized, but it is known to encode a protein with multiple functions, including interaction with various cellular signaling pathways. Several studies have identified LOC105379007 as a potential drug target and biomarker, which could be useful for the development of new therapeutic approaches for various diseases. Further research is needed to fully understand the role of LOC105379007 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC105379007

The "LOC105379007 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105379007 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144 | LOC105379164 | LOC105379168 | LOC105379171 | LOC105379174 | LOC105379176 | LOC105379185 | LOC105379193 | LOC105379232 | LOC105379235 | LOC105379242 | LOC105379243 | LOC105379289 | LOC105379297 | LOC105379314 | LOC105379315 | LOC105379318 | LOC105379341 | LOC105379344 | LOC105379362 | LOC105379365 | LOC105379382 | LOC105379385 | LOC105379395 | LOC105379399 | LOC105379490 | LOC105379514 | LOC105379570 | LOC105379599 | LOC105379614 | LOC105379647 | LOC105379648 | LOC105379652 | LOC105379656 | LOC105379658 | LOC105379660 | LOC105379663 | LOC105379664 | LOC105379665 | LOC105379667 | LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536